Virtual cells will still be just computer models. Synthetic biology’s masterpiece—in the word’s original sense of a work ...

A new review maps how anesthetics and surgical stress disrupt circadian and melatonin signaling, and why better-designed ...

Cumulus Neuroscience, the digital biomarker company behind the NeuLogiq® Platform, and Transpharmation Ltd., a scientist-led ...

Transdermal drug delivery systems are pharmaceutical formulation systems that combine active ingredients with carriers such ...

A validated translational platform linking lesion drug penetration to Phase 3 trial outcomes offers a new way to design ...

Siemens Digital Industries Software unveiled "Intelligence Center X," an integrated enterprise AI agent platform, on the 13th ...

The global threat of antimicrobial resistance necessitates an integrated roadmap to accelerate development and equitable use ...

SR One's Simeon George argues that the biggest returns from AI in drug development come from improving early-stage decisions, not from predicting ...

How an oncologist’s sci-fi insight, layoffs at a pharma giant, and the culture of Research Triangle Park birthed a major cancer innovation.

People living with dementia and their families will benefit from a major new partnership making it easier to join clinical ...

GSK (LSE:GSK) announced a new collaboration with Chai Discovery to apply AI-driven protein design in its drug discovery ...

In recent weeks, GSK has begun implementing large-scale job cuts in Belgium and closing a German vaccine site as part of a ...